Cue Biopharma
Clinical-stage biopharmaceutical company developing Immuno-STAT immunotherapy platform to selectively engage and modulate disease-specific T cells for cancer treatments including HPV-driven cancers and hematologic malignancies.
About
What Cue Biopharma is
Clinical-stage biopharmaceutical company developing Immuno-STAT immunotherapy platform to selectively engage and modulate disease-specific T cells for cancer treatments including HPV-driven cancers and hematologic malignancies.
losclouds keeps public details for this profile. There are no catalog offerings to compare yet.
EnterpriseHealthcare
At a glance
| Fact | Value |
|---|---|
| Official site | https://cuebiopharma.com |
| Status coverage | Public status page |
| Founded | 2014 |
| Headquarters | Boston, Massachusetts, United States |
| Categories | Enterprise, Healthcare |
Loading offerings...